Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 1997

View Archived Issues

Tokyo Tanabe discloses beta3-adrenoceptor agonists

Protein tyrosine kinase inhibitors from Kyowa Hakko

Novel antitumor agents from Kyowa Hakko

Prokinetic agents disclosed by Zeria

SKB reports new delta-receptor agonists/antagonists

New antibiotics from BTG

Chiroscience investigates MMP/TNF inhibitors

Abbott discloses antibacterial tiacumicin derivatives

New antihistamines in the pipeline at HMR

Biochemie reports new cephalosporins

Ortho reports analgesic drug candidates

Johns Hopkins investigators report new growth factor

Neuroprotective agent described by Taisho

Schering-Plough develops dual PAF and histamine antagonist

Fujisawa characterizes novel antidementia agent

Paracelsian signs CRADA with NCI

Avonex update presented

Long-acting calcium channel blocker proves effective in post-MI patients

Pharmacia & Upjohn's Estring now available on U.S. market

First launch for AccuSite

New approvals for Zagam

Fluasterone enters phase I as breast cancer prevention agent

Integrilin scheduled for review

Generic version of Monistat-7 approved by FDA

February review for Medco's vasodilator combination

Approval sought for Androtest-SL

Genelabs completes first pivotal trial on SLE Rx

Cel-Sci receives award for TB diagnostic

ArQule and Signal expand drug discovery agreement

Lilly and TheraTech drug collaboration

New impotence Rx now available in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...